News
![AbbVie upscales Voyager alliance with new target, more cash](/sites/default/files/styles/x_large/public/default_images/empty.jpg?itok=C-Mgnvzj)
AbbVie upscales Voyager alliance with new target, more cash
AbbVie has extended its collaboration with gene therapy specialist Voyager Therapeutics, adding a new programme in Parkinson’s disease and another $1.5 billion in potential fees.